
News|Articles|October 2, 2004
- Pharmaceutical Technology-10-02-2004
- Volume 28
- Issue 10
USP General Notices and General Test Chapters: Interpretations and Misinterpretations
Author(s)Susan J. Schniepp
The authors dispel common misinterpretations of the United States Pharmacopeia.
Advertisement
Articles in this issue
over 21 years ago
A Novel Freeze Pelletization Technique for Preparing Matix Pelletsover 21 years ago
Aseptic Processing: A Review of Current Industry Practiceover 21 years ago
Can Inserts Be Improved?over 21 years ago
Drug Development Linked More Closely to Diagnosticsover 21 years ago
In The Spotlight-October 2004over 21 years ago
October 2004over 21 years ago
The High Price of SuccessNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Navigating AI, Sustainability, and Operational Resilience
2
Integrating AI and Machine Learning in Drug Discovery and Development
3
Single-Use Systems Enable Commercial-Scale CGT Manufacturing
4
EMA and FDA Collaborate on Framework for AI Use in Drug Development
5




